25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 3, 2011, Pages 311-319

  Vaidya, Anand ^a   Forman, John P ^a,b   Hopkins, Paul N ^c   Seely, Ellen W ^a   Williams, Jonathan S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; hypertension; renin; sodium; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; RENIN; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA RENIN ACTIVITY; SODIUM INTAKE;

CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENIN; SODIUM, DIETARY; VITAMIN D;

EID: 80052377405     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310391922     Document Type: Article

References (59)

1. Weinberger MH Salt sensitivity of blood pressure in humans. Hypertension 1996 ; 27: 481-490. (Pubitemid 26084617)
2. Johnson RJ, Herrera-Acosta J., Schreiner GF and Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002 ; 346: 913-923. (Pubitemid 34984641)
3. Resnick LM, Muller FB and Laragh JH Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986 ; 105: 649-654. (Pubitemid 17176965)
4. Resnick LM, Nicholson JP and Laragh JH Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed Proc 1986 ; 45: 2739-2745. (Pubitemid 17187443)
5. Burgess ED, Hawkins RG and Watanabe M. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990 ; 3: 903-905.
6. Vaidya A. and Forman JP Vitamin D and hypertension: current controversies and future directions. Hypertension 2010 ; 56 (5). 774-9
7. Erne P., Bolli P., Burgisser E. and Buhler FR Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med 1984 ; 310: 1084-1088. (Pubitemid 14131501)
8. Shan J., Resnick LM, Lewanczuk RZ, Karpinski E., Li B. and Pang PK 1,25-dihydroxyvitamin D as a cardiovascular hormone. Effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens 1993 ; 6: 983-988.
9. Nicholson JP, Resnick LM, Cigarroa J., Marion D., Vaughan ED, Jr and Laragh JH The pressor effect of sodium-volume expansion is calcium mediated. Am J Hypertens 1991 ; 4: 904-908.
10. Resnick LM, Nicholson JP and Laragh JH The antihypertensive effects of calcium channel blockade: role of sodium and calcium metabolism. J Cardiovasc Pharmacol 1988 ; 12 (Suppl. 6). S114 - S116. (Pubitemid 19056626)
11. Resnick LM Calciotropic hormones in human and experimental hypertension. Am J Hypertens 1990 ; 3: 171S - 178S. (Pubitemid 20287347)
12. Resnick LM Calciotropic hormones in salt-sensitive essential hypertension: 1,25-dihydroxyvitamin D and parathyroid hypertensive factor. J Hypertens Suppl 1994 ; 12: S3 - S9. (Pubitemid 24082253)
13. Resnick LM Uniformity and diversity of calcium metabolism in hypertension. A conceptual framework. Am J Med 1987 ; 82: 16-26.
14. Lind L., Wengle B., Wide L. and Ljunghall S. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989 ; 2: 20-25. (Pubitemid 19031898)
15. Naftilan AJ and Oparil S. The role of calcium in the control of renin release. Hypertension 1982 ; 4: 670-675. (Pubitemid 13239684)
16. Beierwaltes WH The role of calcium in the regulation of renin secretion. Am J Physiol Renal Physiol 2010 ; 298: F1 - F11.
17. Li YC, Kong J., Wei M., Chen ZF, Liu SQ and Cao LP 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002 ; 110: 229-238. (Pubitemid 34787360)
18. Li YC Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003 ; 88: 327-331. (Pubitemid 36119906)
19. Zhang Y., Deb DK, Kong J., et al. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol 2009 ; 297: F791 - F801.
20. Zhang Y., Kong J., Deb DK, Chang A. and Li YC Vitamin D receptor attenuates renal fibrosis by suppressing the renin- angiotensin system. J Am Soc Nephrol 2010 ; 21: 966-973.
21. Forman JP, Williams JS and Fisher ND Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010 ; 55: 1283-1288.
22. Vaidya A., Forman JP and Williams JS Vitamin D and the Vascular Sensitivity to Angiotensin II in Obese Caucasians with Hypertension. Journal of Human Hypertension 2010 ; in press.
23. Holick MF, Siris ES, Binkley N., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005 ; 90: 3215-3224. (Pubitemid 41014278)
24. Holick MF Vitamin D deficiency. N Engl J Med 2007 ; 357: 266-281.
25. Holick MF and Chen TC Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008 ; 87: 1080S - 1086S. (Pubitemid 351549267)
26. Kotchen TA, Ott CE, Whitescarver SA, Resnick LM, Gertner JM and Blehschmidt NG Calcium, parathyroid hormone, and vitamin D in the "prehypertensive" Dahl salt-sensitive rat. Am J Hypertens 1990 ; 3: 167S - 170S. (Pubitemid 20287346)
27. Raji A., Williams GH, Jeunemaitre X., et al. Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens 2001 ; 19: 99-105. (Pubitemid 32099281)
28. Williams JS, Williams GH, Jeunemaitre X., Hopkins PN and Conlin PR Influence of dietary sodium on the renin- angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. J Hum Hypertens 2005 ; 19: 133-138. (Pubitemid 40227370)
29. Price DA, Fisher ND, Lansang MC, Stevanovic R., Williams GH and Hollenberg NK Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension 2002 ; 40: 186-189. (Pubitemid 34840096)
30. Price DA and Fisher ND The renin-angiotensin system in blacks: active, passive, or what? Curr Hypertens Rep 2003 ; 5: 225-30.
31. Forman JP, Price DA, Stevanovic R. and Fisher ND Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan. J Hypertens 2007 ; 25: 877-882. (Pubitemid 46398884)
32. De'Oliveira JM, Price DA, Fisher ND, et al. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997 ; 52: 771-777. (Pubitemid 27402378)
33. Price DA, De'Oliveira JM, Fisher ND, Williams GH and Hollenberg NK The state and responsiveness of the renin- angiotensin-aldosterone system in patients with type II diabetes mellitus. Am J Hypertens 1999 ; 12: 348-355. (Pubitemid 29200052)
34. Perlstein TS, Gerhard-Herman M., Hollenberg NK, Williams GH and Thomas A. Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol 2007 ; 18: 944-951. (Pubitemid 46434511)
35. Fisher ND, Hurwitz S., Ferri C., Jeunemaitre X., Hollenberg NK and Williams GH Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension 1999 ; 34: 388-394. (Pubitemid 29426752)
36. Fisher ND, Gleason RE, Moore TJ, Williams GH and Hollenberg NK Regulation of aldosterone secretion in hypertensive blacks. Hypertension 1994 ; 23: 179-184. (Pubitemid 24050278)
37. Luft FC, Miller JZ, Grim CE, et al. Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 1991 ; 17: 1102-1108.
38. Kojima S., Murakami K., Kimura G., et al. A gender difference in the association between salt sensitivity and family history of hypertension. Am J Hypertens 1992 ; 5: 1-7.
39. Koolen MI, Bussemaker-Verduyn den Boer E. and van Brummelen P. Clinical biochemical and haemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens Suppl 1983 ; 1: 21-23. (Pubitemid 14186112)
40. Weinberger MH, Miller JZ, Luft FC, Grim CE and Fineberg NS Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986 ; 8: 11127-11134.
41. Ishibashi K., Oshima T., Matsuura H., et al. Effects of age and sex on sodium chloride sensitivity: association with plasma renin activity. Clin Nephrol 1994 ; 42: 376-380.
42. Tomaschitz A., Pilz S., Ritz E., et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Chim Acta 2010 ; 411: 1354-1360.
43. Doorenbos CR, van den Born J., Navis G. and de Borst MH Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 2009 ; 5: 691-700.
44. Pilz S., Tomaschitz A., Drechsler C., Dekker JM and Marz W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010 ; 54: 1103-1113.
45. Pilz S., Tomaschitz A., Ritz E. and Pieber TR Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009 ; 6: 621-630.
46. Forman JP, Giovannucci E., Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007 ; 49: 1063-1069. (Pubitemid 351664326)
47. Resnick LM Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X". Am J Hypertens 1993 ; 6: 123S - 134S. (Pubitemid 23140975)
48. Gennari C., Nami R. and Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner Electrolyte Metab 1995 ; 21: 77-81.
49. Young EW, Morris CD, Holcomb S., McMillan G. and McCarron DA Regulation of parathyroid hormone and vitamin D in essential hypertension. Am J Hypertens 1995 ; 8: 957-964.
50. Imaoka M., Morimoto S., Kitano S., Fukuo F. and Ogihara T. Calcium metabolism in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol 1991 ; 18: 631-641.
51. Hulter HN, Melby JC, Peterson JC and Cooke CR Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986 ; 2: 360-370.
52. Grant FD, Mandel SJ, Brown EM, Williams GH and Seely EW Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 1992 ; 75: 988-992.
53. Fritsch S., Lindner V., Welsch S., et al. Intravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responses. J Am Soc Nephrol 2004 ; 15: 2588-2600. (Pubitemid 41103365)
54. Hagstrom E., Hellman P., Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009 ; 119: 2765-2771.
55. Pilz S., Tomaschitz A., Drechsler C., et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010 ; 31: 1591-1598.
56. Zhao G., Ford ES, Li C., Kris-Etherton PM, Etherton TD and Balluz LS Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 2010 ; 28: 1821-1828.
57. Kong J., Qiao G., Zhang Z., Liu SQ and Li YC Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney Int 2008 ; 74: 1577-1581.
58. Campbell DJ, Nussberger J., Stowasser M., et al. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009 ; 55: 867-877.
59. Tomaschitz A. and Pilz S. Aldosterone to renin ratio-a reliable screening tool for primary aldosteronism? Horm Metab Res 2010 ; 42: 382-391.